Compare HUDI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUDI | COSM |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 13.5M |
| IPO Year | 2019 | 2009 |
| Metric | HUDI | COSM |
|---|---|---|
| Price | $1.22 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.2K | ★ 876.0K |
| Earning Date | 01-30-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | N/A | $20.69 |
| Revenue Next Year | N/A | $53.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $1.06 | $0.28 |
| 52 Week High | $5.46 | $1.32 |
| Indicator | HUDI | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.00 | 53.82 |
| Support Level | $1.09 | $0.35 |
| Resistance Level | $1.30 | $0.41 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 72.27 | 43.36 |
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.